Mirum Pharmaceuticals Inc (MIRM)
NASDAQ
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
Total Revenue | 17.48M | 18.78M | 27.91M | 31.6M | 37.5M | 47.73M | 69.55M | 90.38M |
Operating Income | -31.44M | -32.88M | -34.16M | -27.15M | -24.27M | -25.15M | -32.59M | -12.68M |
Pre Tax Income | -33.49M | -35.69M | -36.29M | -29.93M | -73.72M | -23.34M | -35.43M | -13.89M |
Net Income | -26.92M | -35.71M | -36.43M | -30.13M | -74.04M | -23.59M | -35.66M | -14.24M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -30.3M | -33.07M | -34.75M | -27.96M | -24.55M | -72.9M | -35.41M | -13.77M |
EBITDA | -30.84M | -31.79M | -32.96M | -25.81M | -22.94M | -22.49M | -27.09M | -6.63M |
Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 19.14M | 77.06M | 186.37M |
Operating Income | -17.41M | -54.74M | -104.3M | -173.41M | -131.22M | -109.15M |
Pre Tax Income | -17.35M | -52.53M | -103.26M | -83.95M | -142.07M | -162.42M |
Net Income | -17.35M | -52.55M | -103.27M | -83.99M | -135.67M | -163.42M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -3.406 | -2.325 | -3.468 | -2.746 | -3.671 | -3.506 |
EBIT | -17.41M | -54.76M | -104.49M | -66M | -130.86M | -161.05M |
EBITDA | -17.41M | -54.6M | -103.99M | -172.82M | -127.98M | -98.33M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.